Dongwha Pharm.Co.Ltd Asset Resilience Ratio

Latest as of June 2026: 1.60%

Dongwha Pharm.Co.Ltd asset resilience ratio. Dongwha Pharm.Co.Ltd (000020) has an Asset Resilience Ratio of 1.60% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000020 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩10.44 Billion

≈ $7.07 Million USD Cash + Short-term Investments

Total Assets

₩653.67 Billion

≈ $442.99 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Dongwha Pharm.Co.Ltd (2011–2025)

Asset resilience ratio of Dongwha Pharm.Co.Ltd from 2011 to 2025. This chart shows how Dongwha Pharm.Co.Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Dongwha Pharm.Co.Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Dongwha Pharm.Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000020 asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.44 Billion	1.6%
Total Liquid Assets	₩10.44 Billion	1.60%

Asset Resilience Insights

Limited Liquidity: Dongwha Pharm.Co.Ltd maintains only 1.60% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Dongwha Pharm.Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Dongwha Pharm.Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	29.37%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Shenzhen Chipscreen Biosciences Co SHG:688321	Drug Manufacturers - Specialty & Generic	5.10%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
HPGC Renmintongtai Pharmaceutical Corp SHG:600829	Drug Manufacturers - Specialty & Generic	0.00%

Dongwha Pharm.Co.Ltd Asset Resilience Ratio by Year (2011–2025)

Dongwha Pharm.Co.Ltd asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Dongwha Pharm.Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.72%	₩11.07 Billion ≈ $7.50 Million	₩642.17 Billion ≈ $435.19 Million	-1.16pp
2024-12-31	2.88%	₩17.84 Billion ≈ $12.09 Million	₩619.63 Billion ≈ $419.92 Million	-0.04pp
2023-12-31	2.92%	₩16.51 Billion ≈ $11.19 Million	₩564.97 Billion ≈ $382.87 Million	-12.98pp
2022-12-31	15.91%	₩73.35 Billion ≈ $49.71 Million	₩461.14 Billion ≈ $312.51 Million	+2.28pp
2021-12-31	13.63%	₩61.03 Billion ≈ $41.36 Million	₩447.80 Billion ≈ $303.47 Million	-0.60pp
2020-12-31	14.23%	₩61.73 Billion ≈ $41.84 Million	₩433.81 Billion ≈ $293.99 Million	-7.64pp
2019-12-31	21.87%	₩82.24 Billion ≈ $55.73 Million	₩376.03 Billion ≈ $254.83 Million	+4.85pp
2018-12-31	17.02%	₩63.07 Billion ≈ $42.74 Million	₩370.60 Billion ≈ $251.15 Million	-9.69pp
2017-12-31	26.71%	₩98.09 Billion ≈ $66.48 Million	₩367.23 Billion ≈ $248.86 Million	+17.16pp
2016-12-31	9.56%	₩31.02 Billion ≈ $21.02 Million	₩324.60 Billion ≈ $219.98 Million	+7.66pp
2015-12-31	1.90%	₩6.02 Billion ≈ $4.08 Million	₩317.19 Billion ≈ $214.95 Million	+0.93pp
2014-12-31	0.96%	₩3.02 Billion ≈ $2.05 Million	₩313.07 Billion ≈ $212.17 Million	+0.01pp
2013-12-31	0.96%	₩3.02 Billion ≈ $2.05 Million	₩316.17 Billion ≈ $214.26 Million	-3.98pp
2012-12-31	4.94%	₩16.02 Billion ≈ $10.86 Million	₩324.28 Billion ≈ $219.76 Million	+4.37pp
2011-12-31	0.57%	₩1.92 Billion ≈ $1.30 Million	₩339.43 Billion ≈ $230.03 Million	--

pp = percentage points

About Dongwha Pharm.Co.Ltd

KO:000020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$96.74 Million

₩142.75 Billion KRW

Market Cap Rank

#19085 Global

#905 in Korea

Share Price

₩5150.00

Change (1 day)

-0.77%

52-Week Range

₩4550.00 - ₩6670.00

All Time High

₩28554.43